InMed Pharmaceuticals Inc.
Nasdaq · Healthcare · Pharmaceutical Preparations · Vancouver
INM chart
What traders are saying about $INM
Latest postsInMed Pharmaceuticals Inc. news
- Buying on the cutoff date isn't expected to qualify for InMed (INM)'s proposed payment rights.
Stock Titan ·
- What Does Rights Record Date Mean for InMed (NASDAQ:INM) Merger?
Kalkine Media ·
- InMed Announces CVR Distribution Record Date in Connection with Proposed Merger
Yahoo Finance ·
- Nov. 5 determines which InMed shareholders may qualify for rights to future payments.
Stock Titan ·
- InMed Pharmaceuticals Inc. (INM) Sets Nov. 5 CVR Record Date, Subject to Vote
TradingView ·
- InMed Pharmaceuticals Inc. Estimates – NASDAQ:INM
TradingView ·
- Form 4 InMed Pharmaceuticals Inc.: ADAR1 Capital Management, LLC (10% Owner) For: 16 October
Investing.com Canada ·
- At $1.32 each, ADAR1 funds buy 1,086 InMed Pharmaceuticals (INM) shares.
Stock Titan ·
- How Much Downside Is Left In Liquidia Stock?
trefis.com ·
- InMed Pharmaceuticals Receives Nasdaq Notification Regarding Minimum Shareholders' Equity Compliance
Yahoo Finance ·
- InMed Reports Full Year Fiscal 2026 Financial Results and Provides Corporate Update
Yahoo Finance ·
- Mentari Therapeutics Announces $200 Million Private Placement for Migraine Prevention Pipeline
Yahoo Finance ·
InMed Pharmaceuticals Inc. key financials
| USD | 2026 | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Revenue | – | $4.9M | $4.6M | $4.1M |
| Net income | -$12.6M | -$8.2M | -$7.7M | -$7.9M |
| Diluted EPS | $-3.12 | $-8.36 | $-20.14 | $-3.25 |
| Total assets (year end) | – | $11.2M | $8.5M | $15.3M |
| Cash and equivalents (year end) | – | $7.0M | $3.4M | $9.5M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
- 8-KCURRENT REPORT
- 10-KANNUAL REPORT
- 8-KCURRENT REPORT
- 8-KCURRENT REPORT
- 8-KFORM 8-K
- 8-KCURRENT REPORT
- 8-KFORM 8-K
- 8-KFORM 8-K
- 10-QQUARTERLY REPORT
- 8-KCURRENT REPORT
- 8-KCURRENT REPORT
- 8-KFORM 8-K
About InMed Pharmaceuticals Inc.
- Ticker
- INM (Nasdaq)
- Industry
- Pharmaceutical Preparations
- Headquarters
- Vancouver
- Incorporated in
- British Columbia, Canada
- Fiscal year end
- June 30
- SEC CIK
- 1728328
Frequently asked questions
What exchange is InMed Pharmaceuticals Inc. listed on?
InMed Pharmaceuticals Inc. trades on the Nasdaq under the ticker symbol INM.
What industry is InMed Pharmaceuticals Inc. in?
InMed Pharmaceuticals Inc. is classified by the SEC under "Pharmaceutical Preparations", part of the Healthcare sector on StockTweeting.
Where is InMed Pharmaceuticals Inc. headquartered?
InMed Pharmaceuticals Inc.'s business address on file with the SEC is in Vancouver.
When does InMed Pharmaceuticals Inc.'s fiscal year end?
InMed Pharmaceuticals Inc.'s fiscal year ends on June 30.
How much revenue did InMed Pharmaceuticals Inc. report?
InMed Pharmaceuticals Inc. reported $4.9M in revenue for calendar year 2025, according to its SEC filings.